MassMEDIC’s 21st Annual Conference

When: « Back to Calendar May 3, 2017 @ 8:00 am - 12:30 pm
Where: Boston Convention & Exhibition Center
415 Summer St
Boston,MA 02210
USA
Member Cost: $ 85
Nonmember Cost: $ 110
Contact: MassMEDIC
617 414-1340
info@massmedic.com
Categories: MassMEDIC Events

 

In conjunction with UBM’s Boston BIOMEDevice 2017 

 

Please note: On-Line Registration closes on Monday May 1, 2017 at 5pm.  Walk-ins are Welcome.

s_whitaker_advamed-crop

Program includes:

Focus on MedTech – The Liquid Biopsy

Report: Hospital Priorities – 2017

Panel Discussions on the Status of Key FDA Issues & Federal Payment Models

Keynote:

A Fireside Chat with Scott Whitaker, President & CEO, Advanced Medical Technology Association

MassMEDIC is teaming up with UBM Advanced Manufacturing and holding its 21st Annual Conference in conjunction with the Boston BIOMEDevice Show, May 3-4. In addition to a great line-up of speakers and unparalleled networking opportunities, your conference registration fee provides access to the BIOMEDevice Exhibit Hall, with product demonstrations, specialized tours and over 200 exhibitors.

MassMEDIC’s Annual Conference registration includes a pass to Boston BIOMEDevice Exhibit Hall and a voucher for lunch!

 

CONFERENCE AGENDA

7:00 a.m.

Registration / Continental Breakfast / Networking
 

8:00 a.m.

Welcoming Remarks

Michael P. Phalen, Chairman, MassMEDIC
Executive Vice President and President, MedSurg, Boston Scientific Corporation

Nina Brown, Vice President of Events, UBM

Thomas J. Sommer, President, MassMEDIC
 

8:15 a.m.

Medical Technology Focus – The Liquid Biopsy Chip – Nanotechnology for Diagnosing Metastasis

Balaji Panchapakesan, Ph.D, Associate Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute
 

8:45 a.m.

Panel Discussion – Three Critical Regulatory Issues Facing MedTech

  • Implementing the Breakthrough Pathway for Medical Devices
  • Cybersecurity
  • Real World Evidence

Moderators: Bill Greenrose and Mutahar Shamsi, Deloitte Advisory

Panelists:

  • Jacob Einhorn, COO, Intrinsic Therapeutics
  • Owen Faris, Clinical Trial Director, Office of Device Evaluation, FDA
  • Russell L Jones, National Co-Leader, Medical Device Safety and Security, Deloitte & Touche
  • Elisabeth George, VP Global Regulations & Standards, Philips
     
     

9:45 a.m.

Networking Break

Announcement of Massachusetts Medical Device Development Center, Johnson & Johnson Innovation, JLABS QuickFire Challenge Winner
Robert G. Urban, PhD, Global Head, Johnson & Johnson Innovation Boston
 

10:15 a.m.

Report: Hospitals Look to MedTech for New Services and Solutions
Monish Rajpal, Managing Director, L.E.K. Consulting

 

10:45 a.m.

What’s Ahead for MedTech Reimbursement – A New Paradigm for Payment?

Moderator: Stephen Hull, Principal and Founder, Hull Associates

Panelists:

  • Thomas Barker. Partner, Co-Chair, Healthcare Practice, Foley Hoag, LLP
  • Scott Reid, VP, Healthcare Strategy & Reimbursement, Smith & Nephew
  • Leslie Wise, Vice President, Global Healthcare Economics,  AngioDynamics – Industry Representative, Medicare Evidence Development & Coverage Advisory Committee, Center for Medicare and Medicaid Services
  • Christina Farup, MD, Vice President, HEMA Americas Lead – Health Economics and Market Access for Medical Devices, Johnson & Johnson Medical Device Companies

 

11:45 a.m.

Adjourn to Boston BIOMEDevice – Exhibit Hall – Center Stage
 

12:00 p.m.

How Will MedTech Fare in our New Public Policy Environment?

A Conversation with Scott Whitaker, President and CEO, Advanced Medical Technology Association

Interviewed by: Brian Johnson, Publisher & Co-Founder, MassDevice

 

12:30 p.m.

Conference Adjourns – Attendees Enjoy Lunch and Boston BIOMEDevice

 

SPONSORS